 |
 |
:: Caris Diagnostics Providing KRAS
Mutational Analysis for Colon Cancer Patients Providing Information on Response to Erbitux and Vectibix <more...>
:: Caris Diagnostics Announces Combination with Molecular Profiling Institute <more...>
:: Molecular Profiling Launches Mammostrat™ - A Novel, Molecular-Targeted, Prognostic Test for Breast Cancer <more...>
|
|
|  |
|
TBAC facilitates large patient-based clinical trials or R & D studies <more...>
We also offer assay development and testing services to pharmaceutical and biotech companies <more...> |
|
|
|
Caris MPI was formed by scientific visionaries and drug developers with a proven track record in the medical industry and our team is forging strategic alliances with leading medical firms <more...> |
|
|
